Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma

doi:10.3748/wjg.v28.i21.2302

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7559)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

451

WORD

123

HTML

3468

Figures (1-6)

515

Tables (1-1)

364

Sum=4921

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

242

Download

503

Sum=745

Publishing Process of This Article

Item

Count

Browse

503

Download

1390

Sum=1893

Jun 7, 2022 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Jun 7, 2022; 28(21): 2302-2319
Published online Jun 7, 2022. doi: 10.3748/wjg.v28.i21.2302

Table 1 Clinicopathological characteristics of the study population illustrating the correlation for the percentage of CD3⁺, CD3⁺CD4⁺ and CD3⁺CD8⁺ cells expressing immune checkpoints present in oesophageal adenocarcinoma tumour tissue

Clinical factor	IC expression	Radiation dose	Spearman r	P value (two-tailed)
Lymphovascular invasion	PD-1 CD3⁺	0 Gy	0.6396022	0.046435
Clinical T stage	PD-L1 CD3⁺	0 Gy	0.6411189	0.024659
	PD-1 CD8⁺	2 Gy	-0.7000000	0.016471
	PD-L1 CD3⁺	2 Gy	0.7768986	0.004908
	TIM-3 CD3⁺	2 Gy	0.7171372	0.012993
	TIM-3 CD4⁺	2 Gy	0.7171372	0.012993
	TIM-3 CD8⁺	4 Gy	0.6963106	0.025293
Clinical N stage	PD-L1 CD4⁺	0 Gy	0.8568931	0.000370
	PD-1 CD4⁺	4 Gy	0.7311262	0.016282
	TIM-3 CD4⁺	4 Gy	0.6614951	0.037241
	TIM-3 CD8⁺	4 Gy	0.6614951	0.037241
Pathological T stage	TIGIT CD3⁺	2 Gy	-0.7395740	0.014492
	TIGIT CD3⁺	4 Gy	-0.8964215	0.006267
Pathological N stage	PD-L1 CD4⁺	0 Gy	0.6510135	0.041473
	PD-L1 CD8⁺	2 Gy	-0.6443043	0.044345
	TIGIT CD3⁺	2 Gy	-0.7471188	0.013014
	TIGIT CD4⁺	4 Gy	0.8981774	0.006011

Positive values indicate positive correlation, negative values indicate negative correlation. Spearman correlation. Only significant data shown. Spearman r = 0.40-0.59 moderate, 0.60-0.79 strong and 0.80-1.00 very strong. IC: Immune checkpoint.

Citation: Donlon NE, Davern M, O’Connell F, Sheppard A, Heeran A, Bhardwaj A, Butler C, Narayanasamy R, Donohoe C, Phelan JJ, Lynam-Lennon N, Dunne MR, Maher S, O’Sullivan J, Reynolds JV, Lysaght J. Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma. World J Gastroenterol 2022; 28(21): 2302-2319
URL: https://www.wjgnet.com/1007-9327/full/v28/i21/2302.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i21.2302